Repositioning Candidate Details

Candidate ID: R0748
Source ID: DB05234
Source Type: investigational
Compound Type: small molecule
Compound Name: LGD2941
Synonyms: --
Molecular Formula: C17H16F6N2O2
SMILES: C[C@@H]1CC[C@H]([C@@H](O)C(F)(F)F)N1C1=CC2=C(NC(=O)C=C2C(F)(F)F)C=C1
Structure:
DrugBank Description: LGD2941 is a non-steroidal, selective androgen receptor modulator (SARM) developed jointly by Ligand and TAP.
CAS Number: --
Molecular Weight: 394.3116
DrugBank Indication: For the treatment and prevention of osteoporosis.
DrugBank Pharmacology: LGD2941 is a non-steroidal, selective androgen receptor modulator (SARM). SARMs are a novel class of non-steroidal, orally active molecules that selectively modulate the activity of the androgen receptor (AR) in different tissues, providing a wide range of opportunities for the treatment of many diseases and disorders with large patient populations in both men and women. Tissue-selective AR agonists or antagonists may provide utility in male hormone therapy and the treatment of patients with male hypogonadism, female and male osteoporosis, male and female sexual dysfunction, frailty, prostate cancer, hirsutism, acne, androgenetic alopecia and other diseases.
DrugBank MoA: LGD2941 selectively modulates the activity of the androgen receptor (AR) in different tissues.
Targets: Androgen receptor
Inclusion Criteria: Indication associated